Zolav®: a new antibiotic for the treatment of acne [Corrigendum]
Dinant A, Boulos RA. Drug Des Devel Ther. 2016;10:1235–1242.All mentions of “Zolav” throughout this paper should read “Zolav (a p-carboethoxy-tristyrylbenzene derivative)”.Read the original article
Saved in:
Main Authors: | Dinant A (Author), Boulos RA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zolav®: a new antibiotic for the treatment of acne
by: Dinant A, et al.
Published: (2016) -
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
by: Nanda K, et al.
Published: (2013) -
A Clinical Investigation of the Performance and Safety of Epaderm®, an Emollient Cream [Corrigendum]
by: August S, et al.
Published: (2021) -
Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma
by: Tan RA, et al.
Published: (2014) -
Topical antibiotics for acne treatment
by: L. V. Silina, et al.
Published: (2017)